UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit

Alimentary pharmacology & therapeutics, 2013-10, Vol.38 (8), p.935-945

2013

Volltextzugriff (PDF)

Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis

The American journal of gastroenterology, 2009-03, Vol.104 (3), p.673-678

2009

Volltextzugriff (PDF)

The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5‐year UK inception cohort

Alimentary pharmacology & therapeutics, 2006-07, Vol.24 (2), p.319-330

2006

Volltextzugriff (PDF)

Systematic review: the use of thiopurines or anti‐TNF in post‐operative Crohn's disease maintenance – progress and prospects

Alimentary pharmacology & therapeutics, 2014-06, Vol.39 (11), p.1253-1265

2014

Volltextzugriff (PDF)

A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta‐analysis

Alimentary pharmacology & therapeutics, 2013-11, Vol.38 (10), p.1255-1266

2013

Volltextzugriff (PDF)

An analysis of factors influencing short‐term and sustained response to infliximab treatment for Crohn's disease

Alimentary pharmacology & therapeutics, 2003-06, Vol.17 (12), p.1451-1457

2003

Volltextzugriff (PDF)

Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis

Gut, 2008-10, Vol.57 (10), p.1398-1405

2008

Volltextzugriff (PDF)

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

Alimentary pharmacology & therapeutics, 2014-12, Vol.40 (11-12), p.1313-1323

2014

Volltextzugriff (PDF)

The safety profile of anti‐tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient‐years follow‐up

Alimentary pharmacology & therapeutics, 2009-02, Vol.29 (3), p.286-297

2009

Volltextzugriff (PDF)

A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis

Alimentary Pharmacology and Therapeutics, 2007-08, Vol.26 (3), p.411-419

2007

Volltextzugriff (PDF)

Tolerability and safety of mercaptopurine in azathioprine‐intolerant patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2008-02, Vol.27 (3), p.220-227

2008

Volltextzugriff (PDF)

Anti‐Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations

Clinical and experimental immunology, 2004-03, Vol.135 (3), p.490-496

2004

Volltextzugriff (PDF)

The use of adalimumab in the management of refractory Crohn’s disease

Alimentary pharmacology & therapeutics, 2008-02, Vol.27 (4), p.308-315

2008

Volltextzugriff (PDF)

Efficacy and complications of adalimumab treatment for medically‐refractory Crohn’s disease: analysis of nationwide experience in Scotland (2004–2008)

Alimentary pharmacology & therapeutics, 2009-03, Vol.29 (5), p.527-534

2009

Volltextzugriff (PDF)

Abnormal Intestinal Permeability Predicts Relapse in Inactive Crohn Disease

Scandinavian journal of gastroenterology, 2000, Vol.35 (11), p.1163-1169

2000

Volltextzugriff (PDF)

Anti‐Saccharomyces cerevisiae Antibodies Status Is Associated with Oral Involvement and Disease Severity in Crohn Disease

Journal of pediatric gastroenterology and nutrition, 2009-02, Vol.48 (2), p.161-167

2009

Volltextzugriff (PDF)

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial

Gut, 2003-07, Vol.52 (7), p.998-1002

2003

Volltextzugriff (PDF)

Clinical use of Infliximab in Crohn’s disease: the Edinburgh experience

Alimentary pharmacology & therapeutics, 2001-10, Vol.15 (10), p.1639-1646

2001

Volltextzugriff (PDF)

Endoscopic ultrasonography in the diagnosis and management of suspected upper gastrointestinal submucosal tumours

British journal of surgery, 2002-02, Vol.89 (2), p.231-235

2002

Volltextzugriff (PDF)

Is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?

Alimentary pharmacology & therapeutics, 2002-05, Vol.16 (5), p.857-867

2002

Volltextzugriff (PDF)

The spectrum of ischaemic colitis

European journal of gastroenterology & hepatology, 1999-03, Vol.11 (3), p.295-304

1999

Volltextzugriff (PDF)

The IL23 axis plays a key role in the pathogenesis of IBD

Gut, 2007-10, Vol.56 (10), p.1333-1336

2007

Volltextzugriff (PDF)

Sero-Reactivity to Microbial Components in Crohn's Disease Is Associated with Disease Severity and Progression, but not NOD2 CARD15 Genotype

The American journal of gastroenterology, 2004-12, Vol.99 (12), p.2376-2384

2004

Volltextzugriff (PDF)

Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy

Human molecular genetics, 2007-09, Vol.16 (18), p.2175-2186

2007

Volltextzugriff (PDF)

Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury

European journal of gastroenterology & hepatology, 2000-05, Vol.12 (5), p.569-574

2000

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(67)

Sprache

Englisch
(67)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(67)
Life Sciences & Biomedicine
(55)
Science & Technology
(55)
Humans
(53)
Female
(43)
Male
(41)
Adult
(36)
Gastroenterology. Liver. Pancreas. Abdomen
(34)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(33)
Other Diseases. Semiology
(29)
Gastroenterology & Hepatology
(28)
Middle Aged
(28)
Pharmacology. Drug Treatments
(21)
Aged
(18)
Adolescent
(16)
Pharmacology & Pharmacy
(15)
Crohn Disease - Drug Therapy
(11)
Follow-Up Studies
(10)
Treatment Outcome
(10)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit

Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis

The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5‐year UK inception cohort

Systematic review: the use of thiopurines or anti‐TNF in post‐operative Crohn's disease maintenance – progress and prospects

A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta‐analysis

An analysis of factors influencing short‐term and sustained response to infliximab treatment for Crohn's disease

Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

The safety profile of anti‐tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient‐years follow‐up

A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis

Tolerability and safety of mercaptopurine in azathioprine‐intolerant patients with inflammatory bowel disease

Anti‐Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations

The use of adalimumab in the management of refractory Crohn’s disease

Efficacy and complications of adalimumab treatment for medically‐refractory Crohn’s disease: analysis of nationwide experience in Scotland (2004–2008)

Abnormal Intestinal Permeability Predicts Relapse in Inactive Crohn Disease

Anti‐Saccharomyces cerevisiae Antibodies Status Is Associated with Oral Involvement and Disease Severity in Crohn Disease

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial

Clinical use of Infliximab in Crohn’s disease: the Edinburgh experience

Endoscopic ultrasonography in the diagnosis and management of suspected upper gastrointestinal submucosal tumours

Is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?

The spectrum of ischaemic colitis

The IL23 axis plays a key role in the pathogenesis of IBD

Sero-Reactivity to Microbial Components in Crohn's Disease Is Associated with Disease Severity and Progression, but not NOD2 CARD15 Genotype

Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy

Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury

Aktive Filter

Suchergebnisse filtern